A Research On The Risk Infection And Immune Of Financial Product Innovation In Commercial Bank

The financial industry has increasingly become the dominant industry of the modern economy and the sustained impetus of the economic development. Chinese commercial banks implement financial innovation is the inevitable choice and development trend. But the credit crisis, starting from the financial crisis, reflects the financial sectors'profound influence to the real economy with a special form in the fields of risk accumulation, risk infection and risk release. In the process of financial innovation of commercial banks, it is very important to strengthen innovation risk and to establish an effective financial product innovation risk management system. Based on the innovation theory, risk management theory, and the artificial immune theory, the disertation studies the risk immunization problem of the financial product innovation of financial institutions.This is the specific contents:Chapter 1 introduction. Introduces the background and significances of the disertation and reviews relative literatures, and put forwards the full analysis framework.Chapter 2 the basic theory of the financial product innovation of commercial bank. Define the connotation of the financial product innovation and the effect, in China, and describes the current financial product innovation of Chinese commercial banks, analyses the existing problems, and discusses the restrictions of the financial product innovation of commercial banks in China.Chapter 3 risks infection model of financial product innovation of commercial bank. Define the connotation of the financial risk, constructs the financial product innovation chain model and analyses its characteristics and operation mechanism, analyzes the commercial banks'financial product innovation risks infection and the rules.Chapter 4 financial product innovation's risk infection elements of commercial banks. Analysis and summarizes the characteristics of commercial bank' financial product innovation risk infection, analyzes the conditions, carrier and and spread paths of the financial product innovation risk infection. Chapter 5 financial product innovation risk immune theory of commercial banks. Reference biological immune concepts, analyzes the basic idea and the immune mechanism of the commercial bank's financial product innovation risk immunization, and constructs the mapping relationship of financial product innovation risk immune model.Chapter 6 financial product innovation risk immune system design and risk monitoring of commercial banks. First, analyzes the design ideas of financial product innovation risk immune system of commercial bank, including the design steps, form space, self antigen and antibody set etc. Second, based on the artificial immune theory, summarizes the financial product innovation risk immunization algorithm, including negative selection, clonal selection and immune evolutionary algorithm, Third, constructs the financial product innovation risk immunization module of commercial banks, and puts forward the immunization strategies;Fourth, constructs a theoretical financial product innovation risk control system based on the residual antigens theory, improving the immunity of the risk control.Chapter 7 case study——significances from the the subprime crisis to commercial banks'financial product innovation. Analyzes the causes, crisis spread conditions, infection paths of the subprime mortgage crisis, constructing the crisis spread chain of the subprime risk, and puts forward the enlightenments to Chinaese commercial bank' financial product innovation risk immunization.The main innovative points are:(1) constructs a financial product innovation chain model; (2) establish the risk infection model based on the small world network (SWN) of the commercial banks'financial product innovation; (3) builds a financial product innovation risk immune model; (4) constructs the financial product innovation risk immunization module of commercial banks, and puts forward the immunization strategies.